Table 1: Baseline characteristics of hospitalized COVID-19 patients.

 

African Americans N = 249 (%)

Caucasians

N = 135 (%)

Others

N = 16 (%)

P-value

Sociodemographic

 

 

 

 

Age

63.3 (14.24)

67.2 (15.32)

57.3 (18.94)

0.009

Females

123 (49.4)

61 (45.2)

7 (43.8)

0.597

Private Insurance

67 (26.9)

26 (19.3)

2 (12.5)

0.151

Comorbidities

 

 

 

 

BMI

31.8 (8.84)

29.5 (7.12)

29.1 (6.31)

0.023

COPD

26 (10.4)

26 (19.3)

1 (6.2)

0.036

Smoking

48 (19.3)

35 (25.9)

2 (12.5)

0.215

GERD

41 (16.5)

29 (21.5)

2 (12.5)

0.4

Diabetes mellitus

106 (42.6)

48 (35.6)

5 (31.2)

0.316

Hypertension

194 (77.9)

88 (65.2)

7 (43.8)

0.001

Heart Failure

38 (15.3)

16 (11.9)

1 (6.2)

0.439

Chronic Kidney Disease

50 (20.1)

21 (15.6)

4 (25)

0.448

Chronic Liver Disease

4 (1.6)

2 (1.5)

0

0.877

HIV

2 (0.8)

1 (0.7)

0

0.937

Home Medications

 

 

 

 

NSAID

97 (39)

45 (33.3)

1 (6.2)

0.023

ACE inhibitors

42 (16.9)

24 (17.8)

2 (12.5)

0.885

ARB

46 (18.5)

8 (5.9)

0

0.001

Beta-blockers

67 (26.9)

30 (22.2)

2 (12.5)

0.305

Statins

98 (39.4)

40 (29.6)

3 (18.8)

0.06

Immunosuppressants

6 (2.4)

7 (5.2) 

1 (6.2)

0.306

Anticoagulants

18 (7.2)

13 (9.6)

0

0.349

BMI: Body Mass Index; COPD: Chronic Obstructive Pulmonary Disease; HIV: Human Immunodeficiency Virus; NSAID: Nonsteroidal Anti-Inflammatory Drugs; ACE: Angiotensin Converting Enzyme; ARB: Angiotensin Receptor Blockers.
Immunosuppressants Include Steroids, Chemotherapies and Anti-TNF- Monoclonal Antibodies.
The baseline characteristics showed that Caucasians in this study were older than African Americans followed by patients from other races. African Americans had the highest BMI (P = 0.023) whereas Caucasians had the highest rate of COPD (P = 0.036) and hypertension (P = 0.001). The number of patients who had NSAID or ARB in their home medication list was significantly different among the different races with higher rates in African Americans (P = 0.023 and P = 0.001, respectively).